Wednesday, September 16, 2009
A Potential Therapeutic Agent For Hepatic Fibrosis
Accumulating evidence suggests that connective tissue growth factor (CCN2) plays a central role in fibrotic conditions in many organ systems. Fibrosis is a scarring condition that is characterized by excessive collagen production that impedes normal cell function and can cause organ dysfunction and failure.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment